These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Streptococcus pyogenes: a rare etiology of non-gonococcal urethritis and balanitis in the adult]. Nicolas X; Granier H; Le Guen P; Chapalain JC; Rouby Y; Talarmin F Med Mal Infect; 2006 Mar; 36(3):170-1. PubMed ID: 16309875 [TBL] [Abstract][Full Text] [Related]
25. [Changes in epidemiology of opportunistic infections due to Candida]. Odds FC Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300 [No Abstract] [Full Text] [Related]
26. Effects of fresh garlic extract on Candida albicans biofilms. Shuford JA; Steckelberg JM; Patel R Antimicrob Agents Chemother; 2005 Jan; 49(1):473. PubMed ID: 15616341 [No Abstract] [Full Text] [Related]
27. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001 [TBL] [Abstract][Full Text] [Related]
28. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278 [TBL] [Abstract][Full Text] [Related]
29. Potential risk factors for infection with Candida spp. in critically ill patients. Peres-Bota D; Rodriguez-Villalobos H; Dimopoulos G; Melot C; Vincent JL Clin Microbiol Infect; 2004 Jun; 10(6):550-5. PubMed ID: 15191384 [TBL] [Abstract][Full Text] [Related]
30. Emergence of Candida albicans fungemia during voriconazole therapy. Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209 [No Abstract] [Full Text] [Related]
31. [Analysis of various factors in Candida albicans infection (proceedings)]. Fegeler W Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):342-5. PubMed ID: 790848 [No Abstract] [Full Text] [Related]
32. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection. Yordanov M; Dimitrova P; Patkar S; Saso L; Ivanovska N Can J Microbiol; 2008 Jun; 54(6):435-40. PubMed ID: 18535628 [TBL] [Abstract][Full Text] [Related]
34. Azole resistance in Candida albicans. Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106 [TBL] [Abstract][Full Text] [Related]
38. [Resistance against Candida is a current problem]. Osterlund A; Strand A Lakartidningen; 1998 Oct; 95(41):4476-7. PubMed ID: 9803739 [No Abstract] [Full Text] [Related]
39. Infectious balanoposthitis: management, clinical and laboratory features. Lisboa C; Ferreira A; Resende C; Rodrigues AG Int J Dermatol; 2009 Feb; 48(2):121-4. PubMed ID: 19200183 [TBL] [Abstract][Full Text] [Related]
40. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Liu XP; Fan SR; Bai FY; Li J; Liao QP Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]